As of Oct 20
| +0.05 / +0.08%|
The 21 analysts offering 12-month price forecasts for Merck have a median target of 65.00, with a high estimate of 82.00 and a low estimate of 56.00. The median estimate represents a +4.97% increase from the last price of 61.92.
The current consensus among 24 polled investment analysts is to Hold stock in Merck. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.